# Bodewell Products for the Treatment of Atopic Dermatitis

> **NCT05566262** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 15 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Bodewell Calming Cream

## Key facts

- **NCT ID:** NCT05566262
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-01
- **Primary completion:** 2027-02
- **Final completion:** 2028-02
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05566262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05566262, "Bodewell Products for the Treatment of Atopic Dermatitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05566262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*